- Report
- December 2022
- 123 Pages
Africa, Middle East
From €3191EUR$3,450USD£2,663GBP
- Report
- December 2022
- 141 Pages
Europe
From €3191EUR$3,450USD£2,663GBP
- Report
- December 2022
- 141 Pages
Asia Pacific
From €3191EUR$3,450USD£2,663GBP
- Report
- August 2022
- 200 Pages
Global
From €4116EUR$4,450USD£3,435GBP
- Report
- October 2023
- 450 Pages
Global
From €2312EUR$2,500USD£1,930GBP
- Report
- October 2023
- 100 Pages
Africa
From €1850EUR$2,000USD£1,544GBP
- Report
- October 2023
- 80 Pages
United States
From €1387EUR$1,500USD£1,158GBP
- Report
- October 2023
- 80 Pages
United Kingdom
From €1387EUR$1,500USD£1,158GBP
From €1387EUR$1,500USD£1,158GBP
- Report
- October 2023
- 80 Pages
South Korea
From €1387EUR$1,500USD£1,158GBP
- Report
- October 2023
- 80 Pages
Saudi Arabia
From €1387EUR$1,500USD£1,158GBP
- Report
- October 2023
- 80 Pages
India
From €1387EUR$1,500USD£1,158GBP
- Report
- October 2023
- 80 Pages
Germany
From €1387EUR$1,500USD£1,158GBP
- Report
- October 2023
- 80 Pages
France
From €1387EUR$1,500USD£1,158GBP
- Report
- October 2023
- 80 Pages
China
From €1387EUR$1,500USD£1,158GBP
- Report
- October 2023
- 350 Pages
Global
From €2312EUR$2,500USD£1,930GBP
- Report
- January 2023
- 170 Pages
Global
From €4116EUR$4,450USD£3,435GBP
- Report
- July 2021
- 151 Pages
Europe
From €3191EUR$3,450USD£2,663GBP
- Report
- June 2025
- 135 Pages
Global
From €4486EUR$4,850USD£3,744GBP
- Report
- April 2025
- 135 Pages
Global
From €4486EUR$4,850USD£3,744GBP

Injectables and infusions are medical treatments that involve the administration of drugs or other substances directly into the body. Injectables are typically administered through a needle or syringe, while infusions are typically administered through a catheter or intravenous line. Injectables and infusions are used to treat a variety of medical conditions, including cancer, diabetes, and autoimmune diseases.
The injectable market is a rapidly growing segment of the pharmaceutical industry. It is estimated that the global injectable market is worth over $100 billion and is expected to grow at a compound annual growth rate of over 8%. The market is driven by the increasing prevalence of chronic diseases, the growing demand for biologics, and the increasing use of self-injectable drugs.
Some of the major players in the injectable market include Pfizer, Merck, Sanofi, Novartis, and Johnson & Johnson. Other companies in the market include Amgen, Bristol-Myers Squibb, Eli Lilly, and AstraZeneca. Show Less Read more